Drug-induced interstitial lung disease during cancer therapies: expert opinion on diagnosis and treatment
Drug-induced interstitial lung disease during cancer therapies: expert opinion on diagnosis and treatment is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Drug-induced interstitial lung disease during cancer therapies: expert opinion on diagnosis and treatment have?
Drug-induced interstitial lung disease during cancer therapies: expert opinion on diagnosis and treatment has 220 citations in the OpenAlex counts ScholarIQ stores.
When was Drug-induced interstitial lung disease during cancer therapies: expert opinion on diagnosis and treatment published?
Drug-induced interstitial lung disease during cancer therapies: expert opinion on diagnosis and treatment has 2022 year in the ScholarIQ index.
What is the open-access status of Drug-induced interstitial lung disease during cancer therapies: expert opinion on diagnosis and treatment?
Drug-induced interstitial lung disease during cancer therapies: expert opinion on diagnosis and treatment has gold oa status in the ScholarIQ index.
What is the DOI of Drug-induced interstitial lung disease during cancer therapies: expert opinion on diagnosis and treatment?
The DOI for Drug-induced interstitial lung disease during cancer therapies: expert opinion on diagnosis and treatment is on the source record.
What is the PMID of Drug-induced interstitial lung disease during cancer therapies: expert opinion on diagnosis and treatment?
The PMID for Drug-induced interstitial lung disease during cancer therapies: expert opinion on diagnosis and treatment is on the source record.
What is the OpenAlex record for Drug-induced interstitial lung disease during cancer therapies: expert opinion on diagnosis and treatment?
The OpenAlex for Drug-induced interstitial lung disease during cancer therapies: expert opinion on diagnosis and treatment is on the source record.